Relafen 750, chemically designated as naproxol, showcases a fascinating case study from a biochemical medicinal viewpoint. Its action of diminishing inflammation involves the targeted inhibition of cyclooxygenase-2 (COX-2), an enzyme vital for the creation of prostanoids, potent regulators of inflammation and pain. Unlike non-selective NSAIDs, Rela